Oruka Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024
Period Ending	Dec '25 Dec 24, 2025	Dec '24 Dec 31, 2024
Market Capitalization	1,555	679
Enterprise Value	1,056	325
Last Close Price	32.12	19.39
PB Ratio	3.21	1.78
P/TBV Ratio	3.21	1.79
Debt / Equity Ratio	0.00	0.00
Quick Ratio	16.65	28.80
Current Ratio	16.94	28.89
Return on Capital Employed (ROCE)	-25.60%	-24.90%
Earnings Yield	-5.37%	-13.46%
FCF Yield	-5.78%	-9.33%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q